Case Study: Leading Pharmaceutical Company achieves actionable physician insights to refine contraceptive prescribing with NetBase Quid

A leading pharmaceutical company wanted to learn more about how physicians view various contraceptive options and what leads them to prescribe their brand

Quid partnered with a leading pharmaceutical company that wanted to understand how physicians view contraceptive options and what drives them to prescribe the client’s brand. The challenge was to uncover the real decision drivers across the patient journey—beyond the client’s hypothesis that cost was the primary barrier—and to identify which physician audiences and messages would most effectively drive adoption.

Quid combined primary research (5,000 physician survey responses) and secondary analysis (50,000+ online physician conversations) using text and network analytics. Findings showed side effects and patient preference dominate the pre‑consult and consult stages while cost mainly surfaces at the decision stage (≈15% of brand conversation is cost‑related). Brand A was top-of-mind for cost mentions, Brand B was chosen for favorable side‑effect profiles and patient preference, and the client brand was discussed more by OBGYNs and recommended for safety, efficacy, and convenience—insights that informed a targeted OBGYN messaging strategy.